Evidence map›Paper›PMID 39720806›Full record

ArticleFrontiers in public health2024

Antibiotic susceptibility testing and molecular characterization based on whole-genome sequencing of

Ziyi Yan, Chenglin Miao, Li Liu, Yunhan Fu, Xingxin Liu, Hong Li, Linghan Kuang, Yali Cui, Yongmei Jiang

Abstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Epidemiology, changing resistance trends and serotypes ofFrontiers in cellular and infection microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ziyi YanDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.
Chenglin MiaoDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.
Li LiuDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.
Yunhan FuDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.
Xingxin LiuDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.
Hong LiKey Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.
Linghan KuangDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.
Yali CuiDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.
Yongmei JiangDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: This study was conducted from August 2022 to September 2023 at a national regional medical center based mainly in West China Second University Hospital, Sichuan University. The demographic and clinical characteristics of Results: The prevalent serotypes in the IPD patients were 14, 6A, and 23F, and the prevalent serotypes in the NIPD patients were 19F and 6A. A significant difference in the proportion of patients with serotype 14 was noted between the two groups. A total of 23 STs were identified and classified into 13 different GPSC lineages, including 4 novel STs (ST18449, ST18451, ST18464 and ST18466) and 1 novel allele ( Conclusion: These data provide valuable information for understanding pediatric pneumococcal disease during the second outbreak of COVID-19 in Southwest China and will contribute to the prevention and treatment of

Indexed as

Anti-Bacterial AgentsCOVID-19Microbial Sensitivity TestsPneumococcal InfectionsStreptococcus pneumoniaeWhole Genome SequencingAdolescentChildChild, PreschoolChinaFemaleHumansInfantMalePandemicsSARS-CoV-2Anti-Bacterial Agentsantibiotic susceptibilityChinamlstNGSpediatricsserotypeStreptococcus pneumoniaevirulence

Identifiers

PMID39720806
PMCPMC11666559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.